Valion Bio(VBIO)
$0.50-0.03 (-4.92%)
VBIO
Valion Bio financials statements
$0.50
At close:-0.03 (-4.92%)
Want to see VBIO full AI Analyst Report?
Valion Bio (VBIO) Financial Statements
175 Followers
Valion Bio Financial Overview
Valion Bio's market cap is currently $1.14M. The company's EPS TTM is $-72.76; its P/E ratio is -0.00; Valion Bio has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 24 | Dec 23 | Mar 23 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 1.18M | $ 0.00 | $ 1.84M | $ 1.26M |
| Gross Profit | $ 0.00 | $ 287.00K | $ -352.00K | $ 299.00K | $ -46.00K |
| Operating Income | $ -7.90M | $ -8.24M | $ -4.42M | $ -10.10M | $ -5.63M |
| EBITDA | $ -7.84M | $ -8.06M | $ -4.06M | $ -9.92M | $ -5.61M |
| Net Income | $ -8.88M | $ -8.24M | $ -5.66M | $ -10.10M | $ -8.49M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 12.64M | $ 3.40M | $ 2.00M | $ 3.52M | $ 12.97M |
| Total Assets | $ 31.61M | $ 5.16M | $ 2.81M | $ 5.88M | $ 15.04M |
| Total Debt | $ 6.45M | $ 369.00K | $ 0.00 | $ 530.00K | $ 708.00K |
| Net Debt | $ -6.19M | $ -3.03M | $ -2.00M | $ -2.99M | $ -12.27M |
| Total Liabilities | $ 14.81M | $ 1.58M | $ 272.00K | $ 2.25M | $ 1.76M |
| Stockholders' Equity | $ 16.80M | $ 3.58M | $ 2.54M | $ 3.63M | $ 13.27M |
| Cash Flow | |||||
| Free Cash Flow | $ -7.04M | $ -8.63M | $ -5.72M | $ -8.93M | $ -5.61M |
| Operating Cash Flow | $ -7.00M | $ -8.51M | $ -5.72M | $ -8.92M | $ -5.61M |
| Investing Cash Flow | $ -705.00K | $ -118.00K | $ 0.00 | $ -11.00K | $ 0.00 |
| Financing Cash Flow | $ 18.35M | $ 8.51M | $ 4.33M | $ -528.00K | $ 17.54M |
Currency in USD
